Skip to content

Manipulating alertness using (exogenous) melatonin and light

Manipulating alertness using (exogenous) melatonin and light - Manipulating alertness

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON47885
Enrollment
20
Registered
2018-03-01
Start date
2017-09-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

alertheid alertness

Interventions

Intervention comprises of: 1) placebo + dim light 2) placebo + bright light 3) melatonin + dim light 4) melatonin + bright light The light conditions are simulated with the use of a Philips Energ
Alertness
Light
Melatonin
Time of day

Sponsors

Rijksuniversiteit Groningen
Lead Sponsor

Eligibility

Age
18 Years to 64 Years

Inclusion criteria

Inclusion criteria: - Age between 20-30 - Healthy - Dutch speaking - Women have to use hormonal contraceptives

Exclusion criteria

Exclusion criteria: - Diagnosed color blindness (ishihara's color blindness test) - Use of photosensitizing medication or sleep medication - Drug use - Moderate to high levels of caffeine intake during a day (5 or more cups) - Smokers - Diabetic disease - Shift work schedule in the 3 months prior to participation - Travel over 2 or more time zones in 1 month prior to participation - Epworth Sleepiness Scale >18 - PSQI

Design outcomes

Primary

MeasureTime frame
The main study parameter is subjective alertness measured by the Karolinska Sleepiness Scale (KSS).

Secondary

MeasureTime frame
Secondary parameters are objective alertness, measured by physiological correlates: pupillary parameters and skin temperature. In addition, indirect parameters, measured through the auditory reaction time task, are used.

Countries

The Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)